CYP11B1 and hypertensive disorder: To study whether AS was a therapeutic target for PA-related hypertension, we generated a transgenic mouse line expressing the hAS coding region (+4–+1115) under the control of the human cyp11B1 promoter (pCYP11B1 (−2015–+3))18 (Fig. 1A).